据了解，该工程项目占地面积约21.45亩，建筑包含地上与地下部分。设计将延续浙大邵逸夫医院 建筑贯通特色，通过连廊与钱塘院区医疗综合楼相连。 质子治疗中心将配套国际先进的360°旋转束质子治疗系统及相关医疗功能区域，包含直加治疗区 （内设直线加速器、CT、MR、PET等先进定位设备）、日间化疗中心及门诊等用房，可为患者提供以 质子治疗为核心的全程化、便捷化、精准化"一站式"诊疗服务，通过优化流程缩短住院时间，最大程度 提升患者就医体验。其中，质子治疗系统采用加速器与治疗室分隔的分体式布局，相较于单机一体式结 构，具有辐射影响小、束流品质高等鲜明优势。 科研转化大楼将配套建设以质子治疗与研究为特色的肿瘤防治技术创新与临床转化平台，并提供系 统化的教学课程与实操训练，助力质子治疗领域专业人才培养，形成科研、教学与临床相互促进的良性 发展格局。 浙江大学医学院附属邵逸夫医院（以下简称"浙大邵逸夫医院"）质子治疗中心暨科研转化大楼工程 项目日前在钱塘院区正式开工，标志着浙江省在质子治疗领域迈出了实质性、关键性的一步。该项目预 计将于2028年10月交付投用。 质子治疗是国际公认的尖端放射治疗技术，能够精准靶向治疗恶性 ...

该质子治疗中心将配套国际先进的360°旋转束质子治疗系统及相关医疗功能区域，包含直加治疗区（内 设直线加速器、CT、MR、PET等先进定位设备）、日间化疗中心及门诊等用房，旨在为患者提供以质 子治疗为核心的全程化、便捷化、精准化"一站式"诊疗服务，通过优化流程缩短住院时间，最大程度提 升患者就医体验。这套质子治疗系统采用加速器与治疗室分隔的分体式布局，相较于单机一体式结构， 具有辐射影响小、束流品质高等鲜明优势。 商报讯（记者 王然 通讯员 李文芳 张冰清）昨日，浙江大学医学院附属邵逸夫医院（以下简称"浙大邵 逸夫医院"）质子治疗中心暨科研转化大楼工程项目开工仪式在钱塘院区举行，标志着浙江省在质子治 疗领域迈出了实质性、关键性的一步。 据了解，质子治疗是国际公认的尖端放射治疗技术，能够精准靶向治疗恶性肿瘤，相较于传统放疗，可 更有效地保护周围正常组织，尤其适用于紧贴脑干、脊髓、视神经、心脏或儿童重要生长中枢的肿瘤治 疗。我国肿瘤患者基数庞大，每年新增需放疗的癌症患者约百万例，对多样化、高品质的医疗技术的需 求日益迫切。目前，全球质子治疗中心超百家，我国正持续加大在这一领域的投入力量，以期让更多患 者获益。 浙 ...

"鼻子不堵了，舒服多了！"近日，在北京协和医院的"国疗开放日"活动上，68岁的加拿大人佛朗哥·卡 普托体验了中医耳针治疗。 2023年，佛朗哥在北京协和医院国际医疗部治好了肠息肉、胃食管反流和幽门螺杆菌感染。此后，他每 年都会来中国看病。他说，虽然加拿大有家庭医生，但是等待时间很长，也不一定治得好。 从渴望早日看好胃病，到期盼更快做上核磁，不远万里来华就医的故事近日频频见诸网络。外国人是 否"扎堆"来华就医？ 多家医院有关负责人告诉记者，从本院诊疗情况看，当前，外籍患者人数在全院患者总人数中占比较 小，但呈增长态势；随着我国持续扩容免签"朋友圈"，旅游中遇到紧急情况看急诊的外国患者也有所增 多。 #68岁加拿大人每年来中国看病#【#老外为何舍近求远来中国看病#】一名外国博主饱受胃痛折磨，因在 本国就医效率太低，远渡重洋来中国看病——最近，在社交媒体上走红的类似视频，引发人们对外国 人"扎堆"来华就医的讨论。 业内人士认为，越来越多外国人来华就医，一个重要原因是中国医疗服务在一些领域具备独特优势。 体验"医在中国"的外国人是否越来越多？他们为何"舍近求远"？这对我国居民就医有怎样的影响？ 国家卫生健康委医政司有 ...

据交易所数据显示， 国际医学8天4板，今日于9时41分封涨停，成交额12.49亿元，换手率9.41%。金融 界App AI线索挖掘：近期 医疗服务板块表现活跃，国际医学被确立为国际医疗旅游试点示范基地，充 分利用自身资源平台对接海外合作伙伴，加强与 一带一路沿线国家在国际医疗旅游服务业务等医疗卫 生领域的交流合作；公司也对包括 脑机接口在内的现代前沿医学技术保持高度关注，本次非公开发行 募集资金拟用于智慧康养项目、质子治疗中心二期项目及补充流动资金，相关业务布局受到市场关注。 风险提示：连板股波动剧烈，注意追高风险，理性投资！（注：以上由AI基于交易所等公开数据生 成，内容不构成投资建议。） ...

Core Insights - The announcement from Meizhong Jiahe marks a significant milestone for its proton therapy center in Guangzhou, indicating a successful transition from technology introduction to capability realization in the medical sector [2][5] - The healthcare industry in China is undergoing a structural adjustment, shifting from a "scale dividend" model to one focused on "capability premium," emphasizing the importance of specialized assets with high technical barriers [2] Group 1: Company Performance - Meizhong Jiahe has demonstrated its strength as an industry "standard setter," participating in the formulation of six national clinical guidelines and establishing a strong academic foundation in proton therapy [3] - The company has achieved a comprehensive breakthrough in clinical breadth, depth, and operational efficiency, completing a closed loop from "heavy asset investment" to "high-quality output" [3][4] - The proton therapy center has shown significant growth in patient intake, indicating a strong brand influence and operational efficiency, with all four treatment rooms operating at full capacity [4] Group 2: Industry Context - The recent "2025 China Social Medical New Ecology Conference" highlighted the need for sustainable clinical output from high-cost medical equipment, which is a critical measure of the level of social medical services [2] - The center's service range extends across 31 provinces and over 20 countries, showcasing its international reach in high-end medical services, particularly in pediatric proton therapy [4] - The completion of China's first proton treatment for ocular malignant melanoma in July 2025 fills a domestic gap and reinforces the center's position in high-difficulty tumor treatments [4]

Core Insights - Jinan International Medical Center is transforming into a national-level health industry hub, leveraging policy benefits, financial support, and high-end medical resources to establish a "high-end, specialized, and international" development pattern by 2025 [1][3][10] Medical Services - The Shandong Proton Center within the medical center has treated nearly 2,000 patients, ranking first in the 2024-2025 China Proton and Heavy Ion Center rankings, showcasing advancements in precision radiation therapy [2] Technological Innovation - The medical center is actively participating in major medical technology exhibitions, introducing innovative technologies such as Hi-tACS for treating neuropsychiatric disorders and AI-assisted diagnostic systems, enhancing the development of precision medicine [4][5] Health Industry Development - The Jinan government is supporting the establishment of a national medical center and accelerating the development of medical parks, ensuring efficient招商 (investment attraction) processes through comprehensive management strategies [6][7] International Cooperation - The medical center is expanding its international collaboration by signing agreements with institutions in South Korea, focusing on various medical fields, and hosting annual Sino-Korean health industry cooperation conferences [8] Resource Support - The Shandong government has introduced tailored policies to support the medical center, including financial backing through various funds, facilitating the approval of medical devices, and enhancing project execution efficiency [9][10]

Group 1 - International Medical aims to create a dual-driven development model of "comprehensive medical care + specialized departments" and has announced a plan to raise up to 1.008 billion yuan through a targeted stock issuance [1] - The raised funds will primarily be invested in smart health care projects, the second phase of the proton therapy center, and to supplement working capital [1] Group 2 - The aging population in China is increasing, with approximately 220 million people aged 65 and above expected by the end of 2024, representing 15.6% of the total population [2] - China's total healthcare expenditure has grown from 3.54 trillion yuan in 2014 to 9.06 trillion yuan in 2023, with a compound annual growth rate of 11.01% [2] - The demand for healthcare services is expected to rise due to the increasing elderly population and enhanced health awareness among residents [2] Group 3 - The proportion of nursing beds in registered elderly care institutions in China was 65.7% by the end of 2024, indicating significant growth potential in the elderly care industry [3] - Policies have been introduced to promote the integration of medical and elderly care services, aiming to improve the care system for elderly individuals with disabilities or dementia [3] Group 4 - Proton therapy is highlighted as a cutting-edge cancer treatment method with high cure rates and low side effects, addressing the limitations of traditional radiation therapy [4] - There is a significant market demand for proton therapy in China, with only seven operational proton therapy centers as of 2024, despite approximately 4.8247 million new cancer cases reported in 2022 [4] Group 5 - The health policy framework aims to enhance cancer prevention and treatment systems by 2030, with a planned increase in the number of radiation therapy devices [5] - The proton therapy center's second phase project aligns with national industrial policy and aims to enhance the company's high-end diagnostic capabilities [6] Group 6 - The implementation of the fundraising projects will enable the company to extend its business from traditional diagnostics to high-end radiation therapy, creating a synergistic business model of "comprehensive diagnosis + precise radiation therapy" [6] - The projects will leverage existing medical resources to strengthen the company's core competitiveness in cancer treatment [6]

Core Insights - Proton therapy represents a breakthrough in radiation therapy, offering unique physical properties that enhance tumor treatment precision and safety [3] - The integration of humanistic care into proton therapy transforms it from a technical procedure into a compassionate healthcare service [6][7] Group 1: Advantages of Proton Therapy - Proton therapy's unique physical characteristics allow for precise energy release at the tumor site, minimizing damage to surrounding healthy tissues, making it particularly suitable for tumors near critical organs [3] - The Guangzhou Taihe Cancer Hospital has established a comprehensive quality control system to ensure the precise implementation of proton therapy, including daily assessments of tumor size and position using CBCT technology [3] Group 2: Humanistic Care in Proton Therapy - The patient-centered service philosophy at Guangzhou Taihe integrates humanistic care throughout the proton therapy process, from initial consultations to ongoing support [6][7] - A complete follow-up support system is in place to monitor patients' recovery and provide health guidance post-treatment, addressing both physical and psychological well-being [7] Group 3: Multidisciplinary Team Collaboration - The implementation of proton therapy requires close collaboration among a multidisciplinary team, including radiation oncologists, medical physicists, radiation therapists, and nursing staff [9] - Guangzhou Taihe emphasizes team building and professional development through systematic training and academic exchanges, ensuring that team members stay updated on the latest technological advancements [9] - Continuous quality improvement activities are conducted to optimize workflows and enhance treatment efficiency, ensuring that every patient receives the best possible care [9]

Core Viewpoint - Proton therapy, recognized as a "precision weapon against cancer," is transforming traditional cancer treatment due to its ability to minimize side effects and enhance patient quality of life through the unique physical property known as "Bragg Peak" [1][2]. Summary by Sections Understanding "Bragg Peak" - Traditional photon therapies, such as X-rays, cause collateral damage to healthy tissues as they penetrate the body, leading to significant side effects [1]. - Proton therapy, utilizing the "Bragg Peak," allows for energy release that is concentrated at the tumor site, minimizing damage to surrounding healthy tissues [2]. Clinical Application and Case Study - A case study of a pancreatic cancer patient demonstrated that over 95% of the radiation dose was concentrated in the tumor, with significantly reduced exposure to surrounding organs, showcasing the protective benefits of "Bragg Peak" [3]. Special Populations and Treatment Efficacy - Proton therapy is particularly beneficial for children, as it reduces the risk of secondary tumors by over 50% compared to traditional therapies, thus preserving their long-term health and quality of life [4]. - The 5-year survival rate for pediatric patients treated with proton therapy is 15%-20% higher than that of traditional methods, with over 90% of children maintaining normal IQ levels post-treatment [4]. Limitations and Complementary Role - Proton therapy is not a universal solution; it has specific indications and cannot fully replace surgery or medication, as these modalities complement each other in cancer treatment [5][6]. - Certain advanced or moving tumors may not be suitable for proton therapy, and surgical intervention remains the preferred option for early-stage cancers [6]. International Comparison and Trends - The 5-year cancer survival rate in China is approximately 43.7%, significantly lower than Japan (66%) and the U.S. (69%), highlighting the need for improved diagnostic and treatment technologies [7]. - The increasing number of proton therapy centers in the U.S. (46 operational and 7 under construction) indicates a growing recognition of its importance in cancer treatment [7]. Patient Trends and Cost Considerations - There is a rising trend of Hong Kong residents seeking proton therapy in mainland China due to limited availability and high costs in Hong Kong, where treatment can exceed 500,000 HKD compared to approximately 300,000 RMB in mainland facilities [8]. - The cost-effectiveness of mainland proton therapy, combined with advanced technology and treatment protocols, is attracting more patients from Hong Kong [8]. Future Directions - The future of proton therapy is expected to focus on precision, localization, and affordability, with the potential for integration with targeted and immunotherapy treatments for mid to late-stage cancers [9].

Core Viewpoint - Proton therapy is recognized as a "precision cancer treatment tool" that significantly alters traditional cancer treatment methods, primarily due to its ability to minimize side effects and enhance patient quality of life through the "Bragg Peak" phenomenon [1][2]. Summary by Sections Understanding "Bragg Peak" - The "Bragg Peak" refers to the unique energy release pattern of charged particles like protons, which allows for concentrated energy delivery at the tumor site while sparing surrounding healthy tissues [1][2]. - Traditional photon therapies, such as X-rays, cause collateral damage to normal tissues, whereas proton therapy can be likened to a "precision missile" that targets only the tumor [2]. Clinical Examples and Efficacy - A case study of a pancreatic cancer patient demonstrated that over 95% of the radiation dose was concentrated in the tumor, with significantly reduced exposure to surrounding organs, showcasing the protective benefits of the "Bragg Peak" [3]. - Proton therapy has been shown to reduce the incidence of secondary tumors by over 50% in pediatric patients, making it a preferred option for treating childhood cancers [4]. Limitations and Complementary Role - Proton therapy is not a universal solution and has specific indications; it cannot replace surgery or medication but can complement them in certain scenarios [5][6]. - For advanced tumors with multiple metastases, proton therapy may have limited effectiveness, and surgical options remain the primary treatment for early-stage cancers [6]. International Comparison and Trends - The five-year cancer survival rates in China (43.7%) lag behind those in Japan (66%) and the U.S. (69%), attributed to differences in tumor types, early diagnosis rates, and treatment protocols [7]. - The increasing demand for proton therapy in mainland China is driven by its cost-effectiveness compared to Hong Kong, where treatment costs are significantly higher [8]. Future Directions - The future of proton therapy is expected to focus on "precision, localization, and accessibility," with advancements in domestic equipment and diversified payment systems anticipated to enhance its integration with targeted and immunotherapy options for mid to late-stage cancers [9].